Autopsy report · NCT02049736

Effect of Telbivudine on Renal Function and Proteinuria in Patients With CHB & Chronic Renal Diseases

“unable to recruit patients”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Chinese University of Hong Kong

Sponsor type

University, hospital or other

Conditions

Chronic Hepatitis B

Interventions

Telbivudine

Participants

0

Sites

1

Countries

Hong Kong

Trials that died the same way

• Individualization Treatment Through a Self-managed Web-based Solution in Ulcerative Colitis
  “not able to recruit patients” (99% match in meaning)
• Bone Healing in Healthy and Post-menopausal Osteoporotic Women
  “Unable to recruit suitable patients” (96% match in meaning)
• The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer
  “Unable to recruit sufficient patients” (94% match in meaning)
• Slings and Their Effect on Skin Pressure
  “unable to recruit patients for study” (90% match in meaning)
• Evaluation of a Support Software in the Planning and Real-time Monitoring of the Insertion of Needles in Interventional Magnetic Resonance Imaging (MRI): Liver Biopsy Case
  “Difficulty recruiting patients” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.